Fibrocell, a cell and gene therapy company, is focused on diseases affecting the skin and connective tissue. Thier approach to personalized biologics is distinctive based on their proprietary autologous fibroblast technology. By extracting fibroblast cells from a patient’s own skin, they create localized gene therapies that are compatible with the unique biology of each patient and have the potential to address the underlying cause of disease.

Vision

To be a leader in creating personalized biologics that have the potential to transform the lives of patients and the future of medicine.

Mission

They are dedicated to developing transformational autologous cell-based therapies that have the potential to offer hope and relief to patients and families suffering from rare genetic diseases affecting the skin and connective tissue.